The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Teva's 2013 sales performance.
We will continue to defend ourselves vigorously in these matters," said Kelley Dougherty, a Teva spokesperson. ... Following the news that Teva is in talks with the DoJ, its shares were up 6.5%.
Under that settlement, Teva would pay $250m in cash over ten years and donate $23bn-worth of drugs to treat opioid addiction, without admitting any wrongdoing. ... rheumatoid arthritis, Teva and Celltrion’s drug is expected to make quick headway in the
This includes all biosimilars, biopharmaceutical contract manufacturing and Glatopa sales – Sandoz’ generic of Teva’s multiple sclerosis drug Copaxone.
Teva is also due to pay $45m in cash and addiction treatments. ... Teva is in the midst of a challenging time financially at the moment so is trying to avoid a cash settlement, opting instead to provide $15bn worth of drugs and some
In addition, Teva Pharmaceuticals has offered medications up to a value of $15bn as part of a proposed deal, and has offered to provide distribution services.
[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...